IL-6-induced anaemia in rats: Possible pathogenetic implications for anaemia observed in chronic inflammations

被引:58
作者
JongenLavrencic, M
Peeters, HRM
Rozemuller, H
Rombouts, WJC
Martens, ACM
Vreugdenhil, G
Pillay, M
Cox, PH
Bijser, M
Brutel, G
Breedveld, FC
Swaak, AJG
机构
[1] DR DANIEL DEN HOED CLIN,DEPT RHEUMATOL,3008 AE ROTTERDAM,NETHERLANDS
[2] ERASMUS UNIV ROTTERDAM,INST HEMATOL,ROTTERDAM,NETHERLANDS
[3] ST JOSEPH HOSP,DEPT INTERNAL MED,VELDHOVEN,NETHERLANDS
[4] DR DANIEL DEN HOED CLIN,DEPT NUCL MED,ROTTERDAM,NETHERLANDS
[5] DR DANIEL DEN HOED CLIN,DEPT PATHOL,ROTTERDAM,NETHERLANDS
[6] UNIV LEIDEN HOSP,DEPT RHEUMATOL,2300 RC LEIDEN,NETHERLANDS
关键词
IL-6; anaemia; chronic disease; anaemia of chronic disease;
D O I
10.1046/j.1365-2249.1996.d01-622.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anaemia of chronic disease (ACD) is frequently found in rheumatoid arthritis (RA). In the pathogenesis of ACD both cytokines, such as tumour necrosis factor-alpha (TNF-alpha), IL-1 and IL-6 as well as a relative deficiency of erythropoietin (EPO), are thought to play a key role. In the present study the role of IL-6 in the pathogenesis of this anaemia was investigated. IL-6 was administered intraperitoneally to rats for 14 sequential days. It appeared that IL-6 was able to induce anaemia. No evidence for suppression of bone marrow erythropoiesis or enhanced sequestration of erythrocytes in the liver was found. However, decreased plasma and bone marrow iron contents were observed in anaemic rats. Blood loss in intestinal tissue was demonstrated using erythrocyte labelling with (99m)technetium. Histologically this was associated with inflammatory cell infiltration, oedema and bleeding in the intestinal wall. In conclusion, IL-6 induced anaemia in rats. This anaemia was caused by intestinal blood loss.
引用
收藏
页码:328 / 334
页数:7
相关论文
共 32 条
[1]  
ASANO S, 1990, BLOOD, V75, P1602
[2]   THE PATHOGENESIS OF ANEMIA IN RHEUMATOID-ARTHRITIS - A CLINICAL AND LABORATORY ANALYSIS [J].
BAER, AN ;
DESSYPRIS, EN ;
KRANTZ, SB .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1990, 19 (04) :209-223
[3]   CIRCULATING SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS, INTERLEUKIN-2 RECEPTORS, TUMOR-NECROSIS-FACTOR-ALPHA, AND INTERLEUKIN-6 LEVELS IN RHEUMATOID-ARTHRITIS - LONGITUDINAL EVALUATION DURING METHOTREXATE AND AZATHIOPRINE THERAPY [J].
BARRERA, P ;
BOERBOOMS, AMT ;
JANSSEN, EM ;
SAUERWEIN, RW ;
GALLATI, H ;
MULDER, J ;
DEBOO, T ;
DEMACKER, PNM ;
VANDEPUTTE, LBA ;
VANDERMEER, JWM .
ARTHRITIS AND RHEUMATISM, 1993, 36 (08) :1070-1079
[4]   ALLEVIATION OF SYSTEMIC MANIFESTATIONS OF CASTLEMANS DISEASE BY MONOCLONAL ANTI-INTERLEUKIN-6 ANTIBODY [J].
BECK, JT ;
HSU, SM ;
WIJDENES, J ;
BATAILLE, R ;
KLEIN, B ;
VESOLE, D ;
HAYDEN, K ;
JAGANNATH, S ;
BARLOGIE, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :602-605
[5]   INTERLEUKIN 1-INDUCED PATHO-PHYSIOLOGY - INDUCTION OF CYTOKINES, DEVELOPMENT OF HISTOPATHOLOGIC CHANGES, AND IMMUNOPHARMACOLOGIC INTERVENTION [J].
BUTLER, LD ;
LAYMAN, NK ;
CAIN, RL ;
RIEDL, PE ;
MOHLER, KM ;
BOBBITT, JL ;
BELAGAJIE, R ;
SHARP, J ;
BENDELE, AM .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 53 (03) :400-421
[6]   ERYTHROPOIESIS AND MEAN RED-CELL LIFESPAN IN NORMAL SUBJECTS AND IN PATIENTS WITH ANEMIA OF ACTIVE RHEUMATOID-ARTHRITIS [J].
DINANT, HJ ;
DEMAAT, CEM .
BRITISH JOURNAL OF HAEMATOLOGY, 1978, 39 (03) :437-444
[7]  
HELLE M, 1991, J IMMUNOL METHODS, V138, P42
[8]  
HERODIN F, 1992, BLOOD, V80, P688
[9]  
HILL RJ, 1991, BLOOD, V77, P42
[10]   REGULATION OF IRON-METABOLISM IN HEPG2 CELLS - A POSSIBLE ROLE FOR CYTOKINES IN THE HEPATIC DEPOSITION OF IRON [J].
HIRAYAMA, M ;
KOHGO, Y ;
KONDO, H ;
SHINTANI, N ;
FUJIKAWA, K ;
SASAKI, K ;
KATO, J ;
NIITSU, Y .
HEPATOLOGY, 1993, 18 (04) :874-880